Claim Missing Document
Check
Articles

Found 13 Documents
Search

Renal Function and Left Ventricular Ejection Fraction in Diabetic Patients with Acute Heart Failure Hutapea, Mery Natalia; Hasan, Refli; Raynaldo, Abdul Halim; Siregar, Abdullah Afif; Haykal, Teuku Bob; Sarastri, Yuke; Ardini, Tengku Winda; Ketaren, Andre Pasha; Purba, Joy Wulansari; Akbar, Nizam Zikri; Andra, Cut Aryfa
Sumatera Medical Journal Vol. 9 No. 1 (2026): Sumatera Medical Journal (SUMEJ)
Publisher : Talenta Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.32734/sumej.v9i1.22989

Abstract

Background: Acute heart failure (AHF) in patients with type 2 diabetes mellitus (T2DM) is frequently complicated by renal dysfunction, which may aggravate cardiac impairment. Serum creatinine may reflect this cardio–renal interaction, but its association with left ventricular ejection fraction (LVEF) in AHF patients with T2DM remains unclear. Objective: To investigate the correlation between serum creatinine and left ventricular ejection fraction (LVEF) in patients with acute heart failure (AHF) and type 2 diabetes mellitus (T2DM). Methods: A cross-sectional study of 52 hospitalized AHF patients with T2DM. Clinical data, serum creatinine, A1C, and echocardiographic LVEF (assessed by two independent consultants) were collected. Correlation and multivariable linear regression analyses were performed. Results: The patients were middle-aged and predominantly male. Mean LVEF was 33.2 ± 9.1%, and mean serum creatinine was 1.58 ± 0.31 mg/dL. Higher serum creatinine levels were strongly associated with lower LVEF. Glycemic status (A1C) and urea levels also showed negative associations with LVEF. After adjustment, serum creatinine and A1C remained independent predictors of reduced LVEF. Conclusion: In AHF patients with T2DM, higher serum creatinine and A1C levels are independently associated with reduced LVEF, underscoring the cardio-renal-metabolic interplay in this population and highlighting the need for integrated management strategies.
Association between atherogenic index of plasma and coronary lesion severity in NSTEMI patients Nasution, Umi Hazzar; Sitepu , Andika; Haykal, Teuku Bob; Siregar, Yasmine; Lubis, Hilfan Ade Putra; Ketaren, Andre Pasha; Hasan, Harris
Heart Science Journal Vol. 7 No. 1 (2026): Accelerating Clinical Breakthroughs: The Journey from Molecular Discovery to Pa
Publisher : Universitas Brawijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.hsj.2026.007.01.13

Abstract

Background: Early identification of the severity of coronary lesions is very important to determine the appropriate management strategy, especially in patients with non-ST-elevation myocardial infarction (NSTEMI). Objective: This study aimed to determine the relationship between the Atherogenic Index of Plasma (AIP) and the severity of coronary lesions in NSTEMI patients. Methods: This study was an analytical observational cross-sectional design conducted at Haji Adam Malik Hospital, Medan, in 2023. Data were collected from medical records of NSTEMI patients and coronary angiography results. Statistical analysis was performed to assess the relationship between AIP and the severity of coronary lesions, including bivariate tests and multivariate logistic regression. Result: A total of 101 NSTEMI patients were included in this study. AIP values were significantly higher in patients with moderate to severe coronary lesions compared to those with mild lesions. An AIP ≥ 0.434 showed a sensitivity of 64.1% and specificity of 67.6% in predicting moderate to severe lesions. Multivariate analysis showed that AIP was the strongest independent predictor of coronary lesion severity, along with age, diabetes mellitus, and ejection fraction. Conclusion: AIP is significantly associated with the severity of coronary lesions in NSTEMI patients and can be used as a simple yet effective risk indicator.
SYNTAX Score II as a Predictor of One-Year Major Adverse Cardiovascular Events in Patients with Chronic Coronary Syndrome and Type 2 Diabetes Mellitus Undergoing Percutaneous Coronary Intervention Elsa Tamara Saragih; Hasan, Harris; Raynaldo, Abdul Halim; Andra, Cut Aryfa; Haykal, Teuku Bob; Ilyas, Kamal Kharazzi
Sumatera Medical Journal Vol. 9 No. 2 (2026): Sumatera Medical Journal (SUMEJ)
Publisher : Talenta Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.32734/sumej.v9i2.23616

Abstract

Background: The severity of coronary atherosclerotic lesions is an important determinant of cardiovascular events in patients with CAD. The SS-II (SYNTAX-II) score, which integrates anatomical characteristics with clinical variables, provides improved prognostic value compared with anatomical scoring alone. Objective: To determine whether the SS-II predicts one-year MACE in CCS patients with T2DM who undergo PCI. Methods: This observational analytic study employed a retrospective cohort design including patients treated from June 2023 to August 2024. A total of 128 CCS patients with T2DM who underwent PCI were enrolled. Bivariate and multivariate analyses were performed to examine the association between the SS-II and MACE. One-year MACE-free survival was analyzed using Kaplan–Meier curves.  Results: MACE occurred more frequently among patients with high SS-II scores (22 [34.4%], P < 0.001). Mortality and acute heart failure were both significantly associated with the SS-II (P = 0.042 and P = 0.03, respectively). Patients with high scores had significantly lower one-year MACE-free survival. Conclusion: The SS-II is a valuable predictor of one-year MACE in CCS patients with T2DM undergoing PCI.